Carregant...

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele
Format: Artigo
Idioma:Inglês
Publicat: BMC 2020-11-01
Col·lecció:Cardio-Oncology
Matèries:
Accés en línia:http://link.springer.com/article/10.1186/s40959-020-00078-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!